Science News

Randall Bateman, MD, thinks we aren’t learning enough from current methods for detecting Alzheimer’s plaques. With a BrightFocus grant, he’s developing an entirely new technology.

In 2003, after his mother was diagnosed with Alzheimer’s, Microsoft co-founder Paul Allen put part of his fortune into brain research. What a fitting legacy for an “idea man,” whose philanthropy remains an inspiration.

On World Alzheimer’s Day, September 21, Stall Catchers will hold a global competition to boost Alzheimer’s research. Learn more about how to watch and even participate!

BrightFocus organized an ARVO 2018 symposium where experts weighed in on exercise, diet, and nutritional supplements for eye health. What research is being done, and are there any benefits for AMD and glaucoma?

The world’s largest vision science meeting is about to begin. ARVO 2018 will showcase BrightFocus leadership and the latest advances in macular degeneration and glaucoma research being from achieved by BrightFocus grantees.

A BrightFocus grantee is adapting MRI and other imaging tests to create a multimodal approach to diagnosing early Alzheimer’s. Earlier diagnosis could mean earlier treatment and cure.

Two new pressure-lowering glaucoma medications have been approved by the FDA and are becoming available in the United States. Each is unique, and one is the first in a new class of drugs.

An expert reveals what recent clinical trials have taught us, and why a one-size-fits-all approach won’t work.

BrightFocus Foundation has joined a new partnership to support innovative science to regenerate damaged visual pathways in glaucoma.